Ecosolex to Showcase Full-Scenario C&I and Residential Energy Storage at ees Europe 2026, Backed by Local European Delivery and Service
MUNICH, June 22, 2026 /PRNewswire/ -- Ecosolex, the energy storage brand of Shenzhen Topband Co., Ltd. (stock code: 002139.SZ), will present its full-scenario commercial & industrial (C&I) and residential energy storage portfolio at ees Europe 2026, part of The smarter E Europe, from June 23 to 25 at Messe München, Hall...
“A Date with China” tour kicks off in Tianjin
BEIJING, Oct. 22, 2021 /PRNewswire/ -- A news report by chinadaily.com.cn on an international media tour in Tianjin: The third leg of the "A Date with China" international media tour kicked off in Tianjin on Friday. Titled "On Road to Prosperity", the third leg, covering Tianjin, Suzhou, Shenzhen and Hainan, will take China-based foreign media correspondents, foreign internet influencers...
Media Alert: Supermicro Announces Open Storage Summit ’24 — Starts August 13
5th Annual Summit Features 7 Sessions with 17 Leading Storage Technology Partners and 30 speakers to Discuss Best Practices and New Developments in Storage for AI, CSP, HPC, HCI and many other Workloads SAN JOSE, Calif., Aug. 8, 2024 /PRNewswire/ -- On August 13, 2024, Supermicro (SMCI) will kick-off its annual Open Storage...
ProWein 2023: Wine of Moldova Commits to Go Sustainable
DÜSSELDORF, Germany, March 30, 2023 /PRNewswire/ -- March 21st 2023: Over the last year, Moldova, with a population of 2m, has opened its doors to over 600,000 refugees from its neighbor, Ukraine. This generosity has earned this former Soviet republic, the description of 'the small country with the big heart'. ...
HD Hyundai Records 30.8953 trillion won Revenue and 1.006 trillion won Operating Profit in H1
Q2 revenue reached 15.6213 trillion won and operating profit 472.6 billion won Shipbuilding, construction equipment and electric power device units achieving solid earnings HD Korea Shipbuilding & Offshore Engineering's revenue at 5.4536 trillion won, up 30.2% YoY H2 earnings expected to stay stable following acceleration of profit improvement in shipbuilding unit and...
Avnet and AMD Showcase Scalable AI Solutions to Accelerate Australia’s Tech Leadership
SYDNEY, Dec. 15, 2025 /PRNewswire/ -- Avnet and AMD have wrapped up the inaugural 'AMD on Wheels' national roadshow, bringing cutting-edge AI and high-performance computing solutions to innovation hubs across Australia. The initiative reaffirmed the partners as definitive industry leaders by demonstrating the critical intersection of AI, sustainability, and commercial acceleration. Demonstrating...
Video Games Industry Elite Gathers In Riyadh For The New Global Sport Conference
Two-Day Event Draws Capacity Lineup of International Celebrities, Thought-Leading Executives and Government Officials 1,200 global delegates arrive in the Kingdom of Saudi Arabia today, including over 200 CEOs from across gaming, esports, technology, sports, entertainment industries Prestigious speaker lineup includes HRH Prince Faisal bin Bandar bin Sultan Al Saud (Chairman of...
ICCPP Ushers “Powder-free” Atomization Technology with Next-Generation GENE TREE Ceramic Cores
SHENZHEN, China, Sept. 18, 2021 /PRNewswire/ -- ICCPP, a global atomization company, has unveiled its first-ever ceramic core technology brand GENE TREE at the 2021 Nano-tech Ceramic Core Global Online Launch Conference on September 16. The release of GENE TREE marks a revolution in electric atomization R&D while also introducing a new generation of ceramic core products into the...
Kelun-Biotech’s Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of SKB378/WIN378
CHENGDU, China, July 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", HKEX: 6990) today announced that its partner, Windward Bio AG ("Windward Bio") has launched its Phase 2 POLARIS clinical study, assessing long-acting dosing of SKB378/WIN378 for people living with asthma. SKB378/WIN378 is a novel, recombinant fully human monoclonal...
Dizal Announces Clinical Results of Golidocitinib Published in Annals of Oncology
SHANGHAI, Sept. 10, 2023 /PRNewswire/ -- Dizal today announced the publication of the Phase I clinical data of golidocitinib for the treatment of relapsed or refractory (r/r) peripheral T cell lymphomas (PTCL) (JACKPOT8 PARTA) in Annals of Oncology (2022-2023 Impact Factor: 51.8). PTCL is an aggressive non-Hodgkin lymphoma (NHL) that represents...







